| Objective: To observe the efficacy of hyperbaric oxygen therapy for insomnia after cerebral infarction. Methods: Forty cases who met the inclusion criteria were divided into treatment group and control group, 20 cases in each group. The control group was treated by the conventional treatment. The treatment group was treated with the conventional teratment and hyperbaric oxygen therapy (120 min each time, once a day, five times a week for four weeks). Two groups were evaluated by Pittsburgh Sleep Quality Index (PSQI), Arsons Insomnia Scale (AIS), Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD) respectively before and 4 weeks after treatment. Results: The total PSQI scores in both groups were significantly decreased after treatment (P<0.05), and those in the treatment group were lower than in the control group (P<0.05). For comparisons of each factor, the scores of subjective sleep quality, sleep latency and habitual sleep efficiency were significantly decreased in two groups after treatment (P<0.05), and the above mentioned scores in the treatment group were lower than those in the control group (P<0.05). In terms of sleep persistence, sleep disturbance and daytime dysfunction, scores of the treatment group were significantly decreased as compared with those before treatment (P<0.05) and lower than those in the control group after treatment. There was no significant difference in the control group before and after treatment (P>0.05). The AIS scores in both groups were significantly decreased after treatment (P<0.05), and the AIS scores in the treatment group were significantly lower than those in the control group (P<0.05). Conclusion: The hyperbaric oxygen therapy can improve scores of PSQI and AIS of insomnia patients after cerebral infarction, especially sleep quality, sleep latency, sleep continuity and sleep disorders. The reasons for improving sleep quality may be related to the improvement in the state of anxiety and depression of patients. |
